Literature DB >> 19491834

Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction.

Amitabh Chak1, Gary Falk, William M Grady, Margaret Kinnard, Robert Elston, Sumeet Mittal, James F King, Joseph E Willis, Anokh Kondru, Wendy Brock, Jill Barnholtz-Sloan.   

Abstract

OBJECTIVES: Adenocarcinomas of the esophagus and adenocarcinomas of the gastroesophageal junction are postulated to be complex genetic diseases. Combined influences of environmental factors and genetic susceptibility likely influence the age at which these cancers develop. The aim of this study was to determine whether familiality and other recognized risk factors are associated with the development of these cancers at an earlier age.
METHODS: A structured validated questionnaire was utilized to collect self-reported data on gastro-esophageal reflux symptoms, risk factors for Barrett's esophagus (BE) and family history, including age of cancer diagnosis in affected relatives from probands with BE, adenocarcinoma of the esophagus, or adenocarcinoma of the gastroesophageal junction, at five tertiary care academic hospitals. Medical records of all relatives reported to be affected were requested from hospitals providing this cancer care to confirm family histories. Familiality of BE/cancer, obesity (defined as body mass index >30), gastroesophageal reflux symptoms, and other risk factors were assessed for association with a young age of cancer diagnosis.
RESULTS: A total of 356, 216 non-familial and 140 familial, cancers were studied. The study population consisted of 292 (82%) men and 64 (18%) women. Mean age of cancer diagnosis was no different in a comparison of familial and non-familial cancers, 62.6 vs. 61.9 years, P=0.70. There were also no significant differences in symptoms of gastroesophageal reflux, body mass index, race, gender, and smoking history between familial and non-familial cancers. Mean age of cancer diagnosis was significantly younger in those who were obese 1 year before diagnosis as compared to those who were non-obese, mean age 58.99 vs. 63.6 years, P=0.008. Multivariable modeling of age at cancer diagnosis showed that obesity 1 year before diagnosis was associated with a younger age of cancer diagnosis (P=0.005) after adjustment for heartburn and regurgitation duration.
CONCLUSIONS: Obesity is associated with the development of esophageal and gastroesophageal junctional adenocarcinomas at an earlier age. Familial cancers arise at the same age as non-familial cancers and have a similar risk factor profile.

Entities:  

Mesh:

Year:  2009        PMID: 19491834      PMCID: PMC2864226          DOI: 10.1038/ajg.2009.241

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  35 in total

1.  The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia.

Authors:  J Lagergren; R Bergström; A Lindgren; O Nyrén
Journal:  Int J Cancer       Date:  2000-02-01       Impact factor: 7.396

2.  Demographic and phenotypic features of 70 families segregating Barrett's oesophagus and oesophageal adenocarcinoma.

Authors:  C M Drovdlic; K A B Goddard; A Chak; W Brock; L Chessler; J F King; J Richter; G W Falk; D K Johnston; J L Fisher; W M Grady; S Lemeshow; C Eng
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

Review 3.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms.

Authors:  Eugenia E Calle; Rudolf Kaaks
Journal:  Nat Rev Cancer       Date:  2004-08       Impact factor: 60.716

4.  Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Authors:  Kenneth K Wang; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2008-03       Impact factor: 10.864

Review 5.  Barrett's esophagus.

Authors:  S J Spechler; R K Goyal
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

Review 6.  Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.

Authors:  Nicholas Shaheen; David F Ransohoff
Journal:  JAMA       Date:  2002-04-17       Impact factor: 56.272

7.  Obesity and estrogen as risk factors for gastroesophageal reflux symptoms.

Authors:  Magnus Nilsson; Roar Johnsen; Weimin Ye; Kristian Hveem; Jesper Lagergren
Journal:  JAMA       Date:  2003-07-02       Impact factor: 56.272

8.  Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults.

Authors:  A Chak; T Lee; M F Kinnard; W Brock; A Faulx; J Willis; G S Cooper; M V Sivak; K A B Goddard
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

Authors:  C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

10.  Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project.

Authors:  Liam Murray; Brian Johnston; Athene Lane; Ian Harvey; Jenny Donovan; Prakash Nair; Richard Harvey
Journal:  Int J Epidemiol       Date:  2003-08       Impact factor: 7.196

View more
  23 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

Review 2.  Barrett's adenocarcinoma of the esophagus: better outcomes through new methods of diagnosis and treatment.

Authors:  Angelika Behrens; Oliver Pech; Florian Graupe; Andrea May; Dietmar Lorenz; Christian Ell
Journal:  Dtsch Arztebl Int       Date:  2011-05-06       Impact factor: 5.594

3.  Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium.

Authors:  Jennifer Drahos; Qian Xiao; Harvey A Risch; Neal D Freedman; Christian C Abnet; Lesley A Anderson; Leslie Bernstein; Linda Brown; Wong-Ho Chow; Marilie D Gammon; Farin Kamangar; Linda M Liao; Liam J Murray; Mary H Ward; Weimin Ye; Anna H Wu; Thomas L Vaughan; David C Whiteman; Michael B Cook
Journal:  Int J Cancer       Date:  2015-08-26       Impact factor: 7.396

4.  The thinking to the huge disease burden of gastric cancer in China and the increasing tendency of esophagogastric junctional adenocarcinoma.

Authors:  Kun Yang; Jian-Kun Hu
Journal:  Transl Gastroenterol Hepatol       Date:  2016-04-13

Review 5.  The Genetics of Barrett's Esophagus: A Familial and Population-Based Perspective.

Authors:  Henry To; Nicholas J Clemons; Cuong P Duong; Alison H Trainer; Wayne A Phillips
Journal:  Dig Dis Sci       Date:  2016-03-12       Impact factor: 3.199

6.  Comparison of endoscopic and clinical characteristics of patients with familial and sporadic Barrett's esophagus.

Authors:  Samuel Ash; Benjamin J Vaccaro; Mary Kay Dabney; Wendy K Chung; Charles J Lightdale; Julian A Abrams
Journal:  Dig Dis Sci       Date:  2011-02-24       Impact factor: 3.199

7.  Fatty acids in a high-fat diet potentially induce gastric parietal-cell damage and metaplasia in mice.

Authors:  Yuki Hirata; Takuhito Sezaki; Miwa Tamura-Nakano; Chinatsu Oyama; Teruki Hagiwara; Takamasa Ishikawa; Shinji Fukuda; Kazuhiko Yamada; Kazuhide Higuchi; Taeko Dohi; Yuki I Kawamura
Journal:  J Gastroenterol       Date:  2016-11-21       Impact factor: 7.527

Review 8.  Diagnosis and management of Barrett's esophagus.

Authors:  Eric M Nelsen; Robert H Hawes; Prasad G Iyer
Journal:  Surg Clin North Am       Date:  2012-08-20       Impact factor: 2.741

9.  Effect of high fat-diet and obesity on gastrointestinal motility.

Authors:  Mazen Al Mushref; Shanthi Srinivasan
Journal:  Ann Transl Med       Date:  2013-07-01

10.  Evaluation of routine biopsies in endoscopic screening for esophagogastric junction cancer.

Authors:  Xin Niu; Wen-Qiang Wei; Chang-Qing Hao; Guo-Hui Song; Jun Li; Zhao-Lai Hua; Yong-Wei Li; Jun Chang; Xin-Zheng Wang; De-Li Zhao; Guo-Qing Wang; Evelyn Hsieh; You-Lin Qiao
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.